Wandercraft raises $75M for acceleration of AI-powered humanoid robotics and exoskeletons

Wandercraft, the self -balanced automatic mobility maker, received $ 75 million financing to accelerate the Acting robots.

The flow of capital during the rapid growth period, the increase in global vision, and the innovation of products in clinical robots, consumers and industrialists.

The D Round series came with major contributions from Renault Group, BPIFRANCE, European Investment Bank, Teampact Ventures and Quarter Management.

The new financing will help to push around the next stage of growth: bringing Eve, the first personal external structure in the world, to the market early in 2026; Expansion of clinical adoption of the main rehabilitation system, Atalante X; Calvin-40, its human robot.

“The momentum we have achieved over the past few years is extraordinary,” Matteo Malasin, CEO of Wandercraft, said in a statement. “We have expanded worldwide, launched the central clinical trials, prepared Eve’s marketing, our personal external structure, entered a prominent partnership with Renault. This financing allows us to continue our mission of converting how people live, move, work through rehabilitation, home environments, and soon on the parties in the facts.”

The news is launched from behind the Wandercraft advertisement with Renault Group, where the manufacturer now owns the ownership of the minority share and a strategic partnership with Wandercraft. The partnership provides industrial experience for Renault Group to expand the production scope of external structures and industrial robots in Wandercraft. Renault is the first commercial partner for Wandercraft and Calvin-40 customer, which has been named for only 40 days developed.

Calvin-40 is an industrial class robot dedicated to the physically difficult tasks-it is appointed to spread production within 40 weeks in Renault factories. The first human robot developed by a European company, Calvin-40 Speedy Development was developed by using the current Robotics platform from Wandercraft, the rapid development process, cooperation with NVIDIA, and the benefit of VLA (visual language model) and Jetson AI. The partnership with Renault lays the basis for the expansion of the effective Eve in terms of cost and the broader Calvin Humanoid family.

In the future, series financing will accelerate:

• Commercial publication of Eve, Personal Structure, in home and outer environments.
• A new stage of growth and support for Atalante X.
• Industrial Development, Calvin-40 and the broader Calvin Humanoid family.

Today’s news has followed a period of significant growth since the company raised the 45 million dollar tour, led by the Quartet, which fueled the American trade expansion and helped increase the number of revenues. Among the other participants in the D Round Lbo France, Mutuelles Impact series – managed by XANGE, Cemag Invest, Martagon Capital and Ag2R La Mondiale.

Wandercraft momentum comes from his dedication to independence to restore independence through hands -free automatic systems that allow straight movement without crutches or pedestrians.

This technology is supported by artificial intelligence and has been tested for life, and was repeated through billions of simulations and dozens of millions of realistic steps.

The result is an increasing list of the first industry and clinical achievements: clinical innovation, supported by artificial intelligence; I got the first clearance of the Food and Drug Administration (FDA) to rehabilitate the Atalante X stroke of the stroke; It is followed by the removal of the second food and drug administration in less than a year, then expanding its use in American hospitals and clinics; The world’s first clinical trial was launched by a personal external balance, Eve, designed to help individuals with severe movement disabilities walk at home and in their societies; Atalante X has been published in more than 100 hospitals and rehabilitation centers worldwide, including the Kesler Foundation, the Villa Bertta Restepain Research Innovation, Vivantes Klinikum Spandau and Schön Klinik.

Wandercraft was evaluated in more than 20 clinical studies. The main results include significant improvements in walking, balance, independence and mode control – often accompanied by reduced pain and cramping and increased muscle strength. 2500 people who suffer from disabilities have been able to take more than 14 million steps so far, re -discovering the freedom of the straight movement that has been considered far from hand.

The company also sought to reach rehabilitation in New York. The company opened “Walk in New York by Wandercraft”, the first walking center that offers external walking sessions for the external structure of people with disabilities in mobility with conditions such as stroke, multiple sclerosis, Parkinson’s and Sci.

The attachment is located inside Cure, a sanitary department for health care in New York City, which also includes the American Wandercraft headquarters. The company intends to establish the center as the first regional center for the deployment of Eve before the expected launch of the United States in 2026.

Creating the product and appreciation

Wandercraft has offered Eve out of the exterior structure in the Olympic flame and disabled in the year 2024, and symbolizes a new global level in transportation technology. It also appeared by Nvidia in CES 2025 and its annual NVIDIA GTC in March. NVIDIA realized the use of Wandercraft for modern technology in NVIDIA and AI materially to enable hands -free hands.

Wandercraft invites individuals to learn more about her continuous clinical experience of Eve, the personal exterior. The study assesses the ability to use in the real world, focusing on ease of movement, endurance, and integration in daily life. Adults between the ages of 18 years and over with a full or incomplete Sci (at T6 or higher) are qualified to participate, provided they have – or can secure it – a bodily capable companion to support. For inquiries or progress, send an e -mail to inclicaltricals@wandercraft.health. The company is employing.

Wandercraft is a robot company on a mission to restore navigation and expand what is possible through self -balance systems, which works on behalf. Wandercraft was established in 2012, and is globally recognized to create the first external walking structure in the world, Atalante X, which is used in more than 100 rehabilitation centers across four continents to help individuals with disabilities take more than a million steps every month. It has more than 30 patents.